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Abstract: Iodine deficiency can be defined as the world’s greatest single cause of 
preventable brain damage. Fetal and neonatal hypothyroidism, caused by iodine deficiency 
can be prevented prior to conception and then during pregnancy and lactation when an 
adequate iodine supplementation is ensured. Extremely low birth weight preterm babies 
risk having a negative iodine balance status in the first weeks of life, exacerbating the 
hypothyroxinaemia of the prematurity. It is important to ensure that these babies are 
provided with an adequate iodine intake from the first days of life. Mothers and newborns 
should avoid environmental iodine excess during pregnancy or lactation. 
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1. Introduction 
Traces of iodine are present in food and water in variable amounts, depending on a number of 
factors. Its concentration in sea-water as iodide is about 50 µg/L. Iodide in seawater is oxidized  
and volatilizes back into the soil through rain. Nevertheless, in mountainous areas or regions where 
frequent flooding occur the iodine water-soil cycle is slower, and water and the soil are deprived of 
iodine [1]. Iodine content in food is variable as it is affected by soil, irrigation, and fertilizers. Seafood 
usually has a higher iodine content. Iodine has a major role within the human body: it is crucial in the 
production of the thyroid hormone. It is absorbed by the stomach and the duodenum and then cleared 
from the blood by the thyroid; before being absorbed, it is converted into iodide ion. 
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When the iodine intake is sufficient, the thyroid clears up about the 10% of the overall element 
circulating in blood, whilst in chronic iodine deficiencies this percentage can exceed 80% [1,2]. The 
active transport of iodine to the thyroid is mediated by the Sodium-Iodine Symporter (NIS) and 
regulated both by the Thyroid Stimulating Hormone and the iodine concentration in blood. Iodine is 
then covalently bound to tyrosine residues in thyroglobulin molecules, forming monoiodotyrosine (MIT) 
and diiodotyrosine (DIT). Thyroid Hormones Tri-iodo-thyronine (T3) and Thyroxine (T4) originate 
from the combination of MIT and DIT after having been separated from thyroglobulin. Circulating T4 
(the most common thyroid hormone) originates entirely from the thyroid, while T3, the active form of 
thyroid hormone, originates mostly from the peripheral deiodination of T4 [3]. Cleaved by the 
peripheral deiodinases the iodine of the thyroid hormones re-enters circulation so that it can be reused 
by the thyroid. The iodine in excess is cleared from the body mainly through urine (90%) and on small 
amounts excreted through feces or sweat. 
Iodine deficiency can be defined as the world’s greatest single cause of preventable brain damage. 
Currently, two billion people worldwide have insufficient iodine intake and 31.5% of children in 
school age have insufficient iodine intake [4]. Several European countries as well are still suffering 
from mild iodine deficiency [5]. This statistics are the drive behind a worldwide campaign to assure  
an adequate supplementation. 
The main strategy to enhance iodine supplementation so far is the Universal Salt Iodization: 
according to WHO (World Health Organization), UNICEF (United Nations International Children’s 
Emergency Fund) and ICCIDD (International Council for the Control of Iodine Deficiency Disorders) 
iodine should be added at a level of 20–40 mg on every kg of salt [1]. Other strategies include bread 
iodization, drinking or irrigation water supplementation, or animal-fodder fortification; nevertheless 
salt iodization is recommended as salt is virtually consumed by everyone throughout the year and 
iodization technology is relatively easy. Important as it is in the synthesis of thyroid hormones, iodine 
plays a major role in the early growth and development of many organs, particularly the brain and the 
central nervous system, and in many metabolic pathways [3]. Consequently, iodine insufficiency, 
occurring when iodine intake falls below recommended levels and the thyroid is no longer able to 
produce enough thyroid hormones, can impair neurodevelopment [3]. When the maternal iodine status 
is insufficient the fetus suffers both from lack of the maternal T4, in a period during which the fetal 
hypothalamic axis is not fully functioning yet, and from impaired fetal hormones production as a 
consequence to the limited fruition of placental iodine. Iodine deficiency is a major threat during 
pregnancy and early childhood as these periods are critical in the development of the neural system of 
the fetus and the child. 
Disorders caused by severe iodine deficiency before or during pregnancy range from decreased 
fertility to trophoblastic or embryonic damage, miscarriage, stillbirth or increased infant mortality, 
cretinism, congenital abnormalities, and psychomotor defects. Neonatal iodine deficiency causes 
neonatal goiter and can lead to moderate to severe hypothyroidism [3]. Two different forms of severe 
neonatal hypothyroidism were recognized in the original description of cretinism [1]: neurological 
cretinism, which consists in its most acute form of severe mental retardation, squint, deafness, and 
motor spasticity; and myxedematous cretinism that leads to severe growth retardation with short 
stature and the typical features of hypothyroidism (but less severe mental retardation) [1]. It is likely 
that neurological cretinism is related to maternal iodine deficiency in the early period of pregnancy 
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while the myxedematous form seems to be related to a lack of iodine in the late pregnancy stages or in 
the first months of life [6]. 
Goiter, hypothyroidism, and impaired cognitive function can also occur during childhood or 
adolescence if iodine supplementation is not sufficient [7]. 
2. Assessing Iodine Deficiency 
Urinary iodine (UI) is a sensible marker of the recent iodine intake. Iodine in excess is mostly 
excreted in urine. Even if the iodine urinary excretion in an individual varies on a daily basis, its 
concentration can be a reliable marker of the recent iodine intake when considering a statistically 
significant number of samples for a certain population. Iodine deficiency is considered to be a major 
problem when the median UI falls below 100 µg/L [1,4,8] (Table 1). 
Table 1. Urinary iodine concentration and iodine intake [1,4,8]. 
Iodine 
Intake 
Median Urinary iodine Concentration 
General 
Population 
Pregnant 
Women 
Lactating 
Women 
Children < 
2 Years Old 
School-Aged 
Children 
Insufficient <100 µg/L <150 µg/L <100 µg/L <100 µg/L <100 µg/L 
Adequate 100–199 µg/L 150–249 µg/L ≥100 µg/L ≥100 µg/L 100–199 µg/L 
More than 
adequate 
200–299 µg/L 250–499 µg/L - - 200–299 µg/L 
Excessive >300 µg/L ≥500 µg/L - >180 µg/L >300 µg/L 
Even if UI is a reliable marker of the iodine status in a certain population, it cannot be used for 
individual diagnosis and treatment. It would be necessary to collect repeated urine samples from  
an individual over a period of time in order to correctly evaluate its iodine status [8]. It can be 
challenging to correctly identify the iodine status in a patient during pregnancy or lactation [9]. Iodine 
is concentrated in the mammary glands, hence the UI can lead to underestimate iodine intake. 
Goiter rate, serum TSH, or Tg levels as well are useful assessments to determine the iodine status in 
a population, while the measurement of thyroid hormones remains a fairly unprecise methodology for 
this endeavor. The UI is a marker for recent iodine intake, whilst goiter rate marks a long-term 
response to iodine deficiency. The latter can be evaluated via neck inspection and palpation or through 
ultrasound scan and it can identify the severity of iodine deficiency in a population. We identify 
iodine-sufficiency when the goiter rate is below the 5%. Goiter rates ranging from 5% to 19.8% 
identify mild deficiency areas, moderately deficient areas ranges between 20% and 29.9% while 
severely deficient regions have goiter rates pushing above 30% [1]. 
TSH could be used as a sensible marker in the neonatal period (it seems to be a reliable indicator of 
even marginal deficiency when measured at three to four days of age) while it is a relatively 
insensitive indicator in older children or in adults. The World Health Organization (WHO) has 
suggested that, when a sensitive Assay is used on samples collected three to four days after birth, a 
<3% frequency of TSH concentrations >5 mIU/L indicates iodine sufficiency in a population [10]. 
Thyroid hormones usually show a variably increased TSH with lower serum T4 and normal/high levels 
of T3. 
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Tg is a sensitive indicator of both low and excess iodine intake (a median Tg that is lower than  
13 μg/L indicates iodine sufficiency in a population) [11]. Crucially, it is also an early marker of 
iodine repletion (it falls quickly after iodine supplementation has started); there is, nevertheless, a risk 
of underestimation when anti-Tg antibodies are present. 
It is important to remember that during pregnancy a small decrease in the concentration of serum 
free T4, a moderate increase of thyroglobulin (Tg) levels or an increase in TSH or Tg levels in cord 
blood samples are not signs of iodine deficiency. 
3. Recommended Dosages of Daily Supplementation According to Age 
Several studies have tried to estimate iodine requirements. In 2001, the U.S. Institute of Medicine 
(IOM) published its recommendation regarding iodine intake using three different categories of dietary 
reference intakes. The three categories are: Estimated Average Requirements (EAR), which indicates 
the daily intake necessary to meet the criterion of adequacy for a certain group of people (the nutrient 
intake of a population is satisfactory when 97%–98% of individuals meet the EAR [12]), Adequate 
Intake (AI), which is obtained by experimental observation and used when there is not enough 
scientific evidence to calculate an EAR, and Recommended Daily Allowance (RDA), which is the 
average daily intake sufficient to provide the gender and age target requirements in nearly all 
individuals and is defined as the EAR plus twice the coefficient of variation in the population (or as the 
140% of the EAR) [13] (see Table 2). 
Table 2. Recommended iodine intakes. 
Source 
Women of 
Reproductive 
Age (µg/day) 
Pregnant 
Women 
(µg/day) 
Lactating 
Women 
(µg/day) 
Newborns and 
Infants (µg/day) 
School Aged 
Children (µg/day)
Institute of 
Medicine 
(IOM), 2001 
95 **  
150 ° 
160 **  
220 ° 
209 **  
290 ° 
110 (0–6 months) *  
130 (7–12 months) *  
65 (1–3 years) **  
90 (1–3 years) ° 
65 (4–8 years) **  
73 (9–13 years) ** 
95 (14–18 years) ** 
90 (4–8 years) °  
120 (9–13 years) ° 
150 (14–18 years) °
Delange, 2004 - 250–300 225–350 90 - 
WHO, 2007 150 250 250 90 120 (6–12 years) 
* Adequate Intake (AI); ** Estimated Average Requirements (EAR); ° Recommended Dietary Allowances 
(RDAs) (140% of the EAR). 
In 2004, Delange [14] suggested his recommended iodine dosage after a critical review of the 
relevant literature. The doses he suggested were 250–300 µg/day during pregnancy, 225–350 µg/day 
during lactation, and 90 µg/day during the neonatal period. 
In 2007, the World Health Organization (WHO) suggested [15], for regions where <90% of 
households have access to iodized salt, a daily dose of iodine supplementation of 250 µg in pregnant or 
lactating women, a daily dose of 150 µg in women of reproductive age—15–49 years—and a daily 
dose of 90 µg in children below two years of age. Infants’ requirements have been calculated roughly 
on the average iodine intake of a healthy baby fed on human milk. Considering that the average iodine 
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concentration in breast milk appears to be about 150–180 µg/L in iodine-sufficient areas, the daily 
iodine production by a mother during lactation has been estimated at about 75–180 µg/day [1]. 
Children within six months of age should only receive iodine through breast milk from  
well-supplemented lactating mothers, or through formula milk with adequate iodine content. Children 
aged seven to 24 months should rather receive supplements as indicated, but only if complementary 
iodine-fortified food is not available. The daily intake for school-age children is 120 µg [16]. The daily 
iodine intake, beyond which no health benefit is expected, is 500 µg for pregnant or lactating women 
(but the safe upper limit for chronic iodine ingestion is not well defined [17]) and 180 µg for children 
of less than two years age. Theoretically, iodine levels that are greater than those listed above could 
impair thyroid function. Newborns are particularly at risk as their gland is immature, and, hence, 
unable to reduce the iodine uptake from blood as a response to excessive exogenous iodine intake 
(Wolff-Chaikoff effect). This last factor explains why transient hypothyroidism or transient increased 
TSH in the newborn can be a consequence of maternal iodine overload (e.g., after the use of povidone 
iodine) especially in areas of moderate deficiency. 
4. Iodine Deficiency in the Newborn 
Studies conducted on healthy preterm and full-term newborns lead to believe that the iodine intakes 
required to maintain a positive balance are 15 µg/kg/day in full-term newborns and 30 µg/kg/day and 
up to 60 µg/kg/day in preterm babies [14]. In fact, as far as preterm babies are concerned, iodine 
deficiency could exacerbate transient hypothyroxinaemia and neither parenteral nutrition nor formula 
milk completely fulfill the iodine requirements. Nevertheless, there is no real evidence that iodine 
supplementation decrease morbidity or mortality in preterm babies [18]. 
Many experts do not recommend routine iodine supplementation in premature babies fed on 
parenteral nutrition. This is because these babies already receive enough iodine by cutaneous 
medicaments (disinfectants) or other adventitious sources of iodine (e.g., IV infusions) [19]. The 
Committee on Clinical Practice Issues of the American Society of Clinical Nutrition recommended, for 
the preterm infant, parenteral intakes of iodine of 1 µg/kg/day even though this is far below their 
requirements [20,21]. 
However, in recent years many efforts have been made towards a “free from iodine excess” 
environment in Obstetrics and Neonatology Units and, for this reason, the “environmental” iodine 
should not be considered anymore as a valuable source. 
A research published on the Cochrane Database in 2006 [18] on randomized or quasi-randomized 
controlled trials—compares a policy of supplementing enteral or parenteral feeding with iodine (more 
than 30 µg/kg/day) vs. placebo or no supplementation in preterm infants, concluding that there were no 
sufficient data to determine whether iodine supplementation could reduce mortality or morbidity in 
preterm babies. No clear data has shown as yet the benefits of prophylactic thyroid hormones in 
preterm infants, in order to reduce neonatal mortality, neonatal morbidity, or improve 
neurodevelopment outcomes so far [22]; a small number of infants enrolled in the tests that document 
this review does not allow to detect moderate, yet clinically important differences on the effects of 
thyroid hormone therapy in preterm infants. Preterm babies born before 30 weeks of gestation are 
prone to transient hypothyroxinaemia. If hypothyroxinemia appears within a crucial period for brain 
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development, preterm babies require particular care in terms of iodine supplementation in order to 
mimic, as much as possible, intrauterine hormone environment [23,24]. 
The cause of hypothyroxinaemia in preterm babies is not fully clear. Iodine deficiency contributes 
to about 30% of cases in enterally fed preterm infants within 27 to 30 weeks of gestation, however, this 
contribution can be greater in younger babies who have a very low parenteral iodine supply [23]. 
According to literature, an enteral intake of at least 30–40 µg iodine/kg/day is required in order to 
achieve a positive iodine balance in healthy preterm infants. The ESPGHAN (European Society for 
Paediatric Gastroenterology, Hepatology and Nutrition) Committee on Nutrition, for example, 
recommends from 11 to 55 µg/kg/day [25]. As the iodine content of preterm formula varies from about 
7 to 25 μg/dL (Table 3), the formula iodine content will not always meet the suggested intakes [26]. 
It is important to remember that iodine content in milk from mothers of preterm babies seems to be 
lower than that of mothers of term babies (100–150 µg/L vs. 150–180 µg/L). Adding fortifiers to 
maternal milk raises iodine content to 20–25 μg/dL. The current standard regimes of parenteral 
nutrition ensure an iodine intake of about 3 µg/kg/day (at 150 mL/kg/day), thus, most infants suffer  
a negative iodine balance in the first weeks of life. 
Table 3. Some of commonly used Preterm Infant Formulas: iodine content. 
Milk Iodine (µg/100 mL) 
Plasmon 0  
Pre Aptamil 
25 
25 
Aptamil PDF  
Mellin 0 Post  
Pre Nidina 
20 
20 
17.3 
Humana 0B  
Miltina 0 
15 
15 
Pre Humana  
Formulat 0 
12 
7.4 
5. Conclusions 
Iodine deficiency can be defined as the world’s greatest single cause of preventable brain damage. 
Important in the synthesis of thyroid hormones, iodine plays a major role in the early growth and 
development of many organs, particularly the brain and the central nervous system, and in many 
metabolic pathways. Consequently iodine insufficiency occurring during pregnancy and early infancy, 
if the maternal/fetal or neonatal thyroid is no longer able to produce enough thyroid hormones, can 
impair neuro-cognitive development. 
Urinary iodine (UI) is a sensible marker of recent iodine intake but it is not reliable for individual 
diagnosis and treatment as it would be necessary to collect repeated urine samples from an individual 
over a period of time in order to evaluate its iodine status. Goiter rate, serum TSH, or Tg levels as well 
are used to assess the iodine status in a population, while thyroid hormones measurement remains  
a fairly unprecise methodology for the detection of iodine deficiency. 
Further research will be useful for better defining methods of assessment of iodine intake and 
iodine status [27]. Prevention of fetal and neonatal hypothyroidism, caused by iodine deficiency, starts 
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prior to conception and then continues during pregnancy and lactation ensuring an adequate iodine 
supplementation. Studies on healthy preterm and full-term newborns lead to believe that the  
iodine intake required to maintain a positive balance are 15 µg/kg/day in full-term newborns and  
30 µg/kg/day, and up to 60 µg/kg/day, in preterm babies. In the term newborn, an adequate iodine 
intake is granted from the first days of age if he or she is formula fed or breastfed by an adequately 
supplemented mother. Extremely low birth-weight preterm babies (newborns with a birth weight 
below 1000 g) are at risk of having a negative iodine balance status in the first weeks of life, 
exacerbating the hypothyroxinaemia of prematurity. It is important that an adequate iodine intake is 
provided for these babies from the first days of life, nevertheless, neither parenteral nutrition or 
formula milk completely fulfill iodine requirements. On the other hand, iodine antiseptics should be 
avoided during pregnancy or lactation and in the newborn: a “free from iodine excess” environment in 
Obstetrics and Neonatology Units should be assured as far as possible. 
More studies are required in order to clearly demonstrate the real benefits deriving from 
supplementation of preterm formulas [18,28], as well as further large prospective studies are urgently 
required to exactly define, not only the short term advantages, but also the long term positive effects 
(for example, on mental development) [29,30] so that a universally accepted iodine supplementation 
plan in preterm babies can be put in place. 
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